Welcome
Support Centre
04 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
A single blind randomised controlled trial to determine the effectiveness of group Cognitive Behaviour Therapy (CBT) in the prevention of depression in high risk adolescents
ISRCTN ISRCTN19083628
ClinicalTrials.gov identifier
Public title A single blind randomised controlled trial to determine the effectiveness of group Cognitive Behaviour Therapy (CBT) in the prevention of depression in high risk adolescents
Scientific title
Acronym N/A
Serial number at source HTA 06/37/04
Study hypothesis Group based CBT delivered in schools is effective and cost effective in preventing depression in adolescents at high risk of depression.

Protocol in: http://www.hta.ac.uk/protocols/200600370004.pdf
Lay summary
Ethics approval Ethics approval received from the University of Bath Ethical Committee: School for
Health: School Research Ethics Approval Panel (SREAP) on the 18th December 2007.
Study design Cluster randomised controlled trial.
Countries of recruitment United Kingdom
Disease/condition/study domain Depression
Participants - inclusion criteria All children aged 13-16 attending participating schools (n = 8-12).
Participants - exclusion criteria No exclusion criteria
Anticipated start date 01/09/2008
Anticipated end date 31/12/2011
Status of trial Completed
Patient information material
Target number of participants 5,000 children of whom 1,000 will be at "high risk" of depression.
Interventions Please note that, as of 11 January 2008, the anticipated end date of this trial has been updated from 30 April 2012 to 30 April 2011. On the 29th April 2008, due to a delay in ethics approval, the anticipated start and end dates have been updated again. The previous dates were:
Anticipated start date: 01/01/2008
Anticipated end date: 30/04/2012

Interventions:
Interventions will be provided during the usual Personal, Social and Health Education (PSHE) sessions (1 hour per session, total of 11 sessions over one school term).

Arm A: Group CBT. CBT recognises the importance of negative thoughts and low self-worth/image in the onset and maintenance of depression. These are therefore actively targeted during CBT with core treatment components including psycho education, identifying and challenging negative/dysfunctional thoughts, identifying personal strengths (thereby enhancing self-esteem/image), managing social problems, and learning to problem solve.

Arm B: Attention placebo. The attention placebo intervention will involve similar time and contact with an external group leader but will not include the active components of the CBT intervention. The content will be based upon the PSHE provided in schools but will be provided by leaders from outside of the school. This will therefore control for the non-specific effects of interventions that are considered important in studies of depression.

Arm C: Usual PSHE
Primary outcome measure(s) Changes in depression symptoms as assessed by the short form Mood and Feelings Questionnaire at 12 months follow-up.
Secondary outcome measure(s) 1. Changes in self-image and negative thoughts. These will be assessed at 12 months by the following questionnaires:
1.1. Self Image Profiles (SIP-A). An easily competed 25-item scale for adolescents assesses how they perceive themselves and how they would like to be. Twelve items assess positive attributes (e.g. confident, fun to be with), twelve assess negative attributes (e.g. annoying, moody) and one is neutral (i.e. feel different from others).
1.2. Children's Automatic Thoughts Scale (CATS). This self-completed scale assesses a range of negative self statements in children and young people aged 7-16. For each item the child is asked to rate whether they have had a similar thought over the past week. Each item is rated as "not at all" (scores 0), "sometimes" (scores 1), "fairly often" (scores 2), "often" (scores 3) or "all the time" (scores 4). The 10-item personal failure sub-scale will be used.
2. Cost effectiveness at 12 months
Sources of funding NIHR Health Technology Assessment Programme - HTA (UK)
Trial website
Publications 1. 2010 results in http://www.ncbi.nlm.nih.gov/pubmed/21114808
Contact name Prof  Paul  Stallard
  Address Department of Child and Family Psychiatry
Royal United Hospital
Combe Park
  City/town Bath
  Zip/Postcode BA1 3NG
  Country United Kingdom
  Tel +44 (0)1225 383860
  Fax +44 (0)1225 825076
  Email paul.stallard@awp.nhs.uk
Sponsor University of Bath (UK)
  Address School for Health
  City/town Bath
  Zip/Postcode BA2 7AY
  Country United Kingdom
  Sponsor website: http://www.bath.ac.uk/health/
Date applied 28/09/2007
Last edited 21/04/2011
Date ISRCTN assigned 01/10/2007
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central